Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/23297
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children |
Author: | Hofman, T. Cranswick, N. Kuna, P. Boznanski, A. Latos, T. Gold, M. Murrell, D. Gebauer, K. Behre, U. Machura, E. Olafsson, J. Szalai, Z. |
Citation: | Archives of Disease in Childhood, 2006; 91(11):905-910 |
Publisher: | British Med Journal Publ Group |
Issue Date: | 2006 |
ISSN: | 0003-9888 1468-2044 |
Statement of Responsibility: | T Hofman, N Cranswick, P Kuna, A Boznanski, T Latos, M Gold, D F Murrell, K Gebauer, U Behre, E Machura, J Ólafsson, Z Szalai |
Abstract: | Background: Concern exists that the prolonged application of immunomodulators to treat atopic dermatitis may cause systemic immunosuppression. Aims: In a 7-month, multicentre, randomised, controlled trial, we investigated the equivalence of response to vaccination against meningococcal serogroup C disease with a protein-conjugate vaccine in children (2–11 years) with moderate to severe atopic dermatitis, by applying either 0.03% tacrolimus ointment (TAC-O; n = 21) or a hydrocortisone ointment regimen (HC-O; n = 111). Methods: TAC-O was applied twice daily (bid) for 3 weeks, and thereafter daily until clearance. 1% hydrocortisone acetate (HA) for head/neck and 0.1% hydrocortisone butyrate ointment for trunk/limbs was applied bid for 2 weeks; thereafter HA was applied bid to all affected areas. At week 1, patients were vaccinated with protein-conjugate vaccine against meningococcal serogroup C, and challenged at month 6 with low dose meningococcal polysaccharide vaccine. The control group (44 non-atopic dermatatits children) received the primary vaccination and challenge dose. Assessments were made at baseline, weeks 1 and 5, and months 6 and 7. The primary end point was the percentage of patients with a serum bactericidal antibody (SBA) titre 8 at the week 5 visit. Results: The response rate (patients with SBA titre 8) was 97.5% (confidence interval (CI) approximately 97.3 to 100), 99.1% (94.8 to 100) and 97.7% (93.3 to 100) in the TAC-O, HC-O and control groups, respectively. Conclusions: The immune response to vaccination against meningococcal serogroup C in children with atopic dermatitis applying either 0.03% TAC-O or HC is equivalent. Ointment application does not affect the immediate response to vaccination, generation of immune memory or humoral and cell-mediated immunity. |
Keywords: | International Tacrolimus Ointment Study Group Humans Neisseria meningitidis, Serogroup C Meningococcal Infections Dermatitis, Atopic Tacrolimus Immunosuppressive Agents Antigens, CD Meningococcal Vaccines Immunoglobulin Isotypes Administration, Topical Double-Blind Method Immunity, Cellular Immunologic Memory Child Child, Preschool Female Male |
Rights: | Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health |
DOI: | 10.1136/adc.2006.094276 |
Published version: | http://dx.doi.org/10.1136/adc.2006.094276 |
Appears in Collections: | Aurora harvest 2 Paediatrics publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_23297.pdf | 231.89 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.